Cisplatin dose rate and nephrotoxicity | Download Table
Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study - The Lancet Oncology
Cumulative doses of chemotherapy. | Download Table
A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity. | Semantic Scholar
Treatment dose of cisplatin and RT of 42 patients | Download Table
Carboplatin/Paclitaxel Induction in Ovarian Cancer: The Finer Points
PDF) Cisplatin dose adjustment in patients with renal impairment, which recommendations should we follow?
Number of patients treated per step and cumulative doses for each patient | Download Table
Frontiers | Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer
Cumulative cisplatin dose is not associated with event‐free or overall survival in children with newly diagnosed average‐risk medulloblastoma treated with cisplatin based adjuvant chemotherapy: Report from the Children's Oncology Group - Rao -
Reduction of Cisplatin-Induced Ototoxicity without Compromising Its Antitumor Activity | Biochemistry
RBORL - Impressão de Artigos
The Cumulative Cisplatin Dose Affects the Long-Term Survival Outcomes of Patients with Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy | Scientific Reports
Cumulative chemotherapy doses | Download Table
Optimal cumulative dose of cisplatin for concurrent chemoradiotherapy among patients with non-metastatic nasopharyngeal carcinom
Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose - ScienceDirect
Cisplatin-induced renal toxicity in elderly people - ZhiYu Duan, GuangYan Cai, JiJun Li, XiangMei Chen, 2020
Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients With Testicular Cancer | JACC: CardioOncology
NCCP Protocol Summary for XXX Drug and XXX Disease
Biomedicines | Free Full-Text | Cisplatin Mouse Models: Treatment, Toxicity and Translatability
Cisplatin is retained in the cochlea indefinitely following chemotherapy | Nature Communications
Characterizing the impact of magnesium and potassium-supplemented hydration with cisplatin and the subsequent electrolyte replacement requirements - So Jung Uhm, Elizabeth Meszaros, Kendall Hammonds, Ina Patel, Jon D Herrington, 2021
Prospective Observational Study of Evaluating Cisplatin-Induced Ototoxicity in Patients
Optimal cumulative dose of cisplatin for concurrent chemoradiotherapy among patients with non-metastatic nasopharyngeal carcinom
The Cumulative Cisplatin Dose Affects the Long-Term Survival Outcomes of Patients with Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy | Scientific Reports
A comparison of cisplatin cumulative dose and cisplatin schedule in patients treated with concurrent chemo-radiotherapy in nasopharyngeal carcinoma - ScienceDirect
